-
1
-
-
84896281400
-
Epidemiology and variability of orthopaedic procedures worldwide
-
Bentley G, ed edn. 12th EFORT Congress, Copenhagen, Denmark. Berlin, Germany: Springer
-
de Pina MDF, Ribeiro AI, Santos C. Epidemiology and variability of orthopaedic procedures worldwide. In: Bentley G, ed. European Instructional Lectures Vol. 11, 11 edn. 12th EFORT Congress, Copenhagen, Denmark. Berlin, Germany: Springer, 2011: 9-19.
-
(2011)
European Instructional Lectures
, vol.11
, pp. 9-19
-
-
de Pina, M.D.F.1
Ribeiro, A.I.2
Santos, C.3
-
2
-
-
34147150632
-
Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030
-
Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg 2007; 89: 780-5.
-
(2007)
J Bone Joint Surg
, vol.89
, pp. 780-785
-
-
Kurtz, S.1
Ong, K.2
Lau, E.3
Mowat, F.4
Halpern, M.5
-
3
-
-
46749131798
-
An estimation of the global volume of surgery: a modelling strategy based on available data
-
Weiser TG, Regenbogen SE, Thompson KD, Haynes AB, Lipsitz SR, Berry WR, Gawande AA. An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet 2008; 372: 139-44.
-
(2008)
Lancet
, vol.372
, pp. 139-144
-
-
Weiser, T.G.1
Regenbogen, S.E.2
Thompson, K.D.3
Haynes, A.B.4
Lipsitz, S.R.5
Berry, W.R.6
Gawande, A.A.7
-
4
-
-
84856797169
-
Prevention of VTE in orthopedic surgery patients
-
Falck-Ytter Y, Francis CW, Johanson NA, Curley C, Dahl OE, Schulman S, Ortel TL, Pauker SG, Colwell CW. Prevention of VTE in orthopedic surgery patients. Chest 2012; 141: e278S-325S.
-
(2012)
Chest
, vol.141
, pp. e278S-e325S
-
-
Falck-Ytter, Y.1
Francis, C.W.2
Johanson, N.A.3
Curley, C.4
Dahl, O.E.5
Schulman, S.6
Ortel, T.L.7
Pauker, S.G.8
Colwell, C.W.9
-
5
-
-
46049090201
-
Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
-
Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, Colwell CW. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133: 381S-453S.
-
(2008)
Chest
, vol.133
, pp. 381S-453S
-
-
Geerts, W.H.1
Bergqvist, D.2
Pineo, G.F.3
Heit, J.A.4
Samama, C.M.5
Lassen, M.R.6
Colwell, C.W.7
-
7
-
-
0030603839
-
Risk of deep venous thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind randomised comparison of enoxaparin versus placebo
-
Planes A, Vochelle N, Darmon JY, Fagola M, Bellaud M, Huet Y. Risk of deep venous thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind randomised comparison of enoxaparin versus placebo. Lancet 1996; 48: 224-8.
-
(1996)
Lancet
, vol.48
, pp. 224-228
-
-
Planes, A.1
Vochelle, N.2
Darmon, J.Y.3
Fagola, M.4
Bellaud, M.5
Huet, Y.6
-
9
-
-
33745632369
-
Venous thromboembolism following major orthopedic surgery: what is the risk after discharge?
-
Arcelus JI, Kudrna JC, Caprini JA. Venous thromboembolism following major orthopedic surgery: what is the risk after discharge? Orthopedics 2006; 29: 506-16.
-
(2006)
Orthopedics
, vol.29
, pp. 506-516
-
-
Arcelus, J.I.1
Kudrna, J.C.2
Caprini, J.A.3
-
10
-
-
84879555624
-
Clinical review: clinical management of new oral anticoagulants: a structured review with emphasis on the reversal of bleeding complications
-
Lazo-Langner A, Lang E, Douketis J. Clinical review: clinical management of new oral anticoagulants: a structured review with emphasis on the reversal of bleeding complications. Crit Care 2013; 17: 230.
-
(2013)
Crit Care
, vol.17
, pp. 230
-
-
Lazo-Langner, A.1
Lang, E.2
Douketis, J.3
-
11
-
-
46049106502
-
Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial
-
Kakkar AK, Brenner B, Dahl OE, Eriksson BI, Mouret P, Muntz J, Soglian AG, Pap AF, Misselwitz F, Haas S. Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial. Lancet 2008; 372: 31-9.
-
(2008)
Lancet
, vol.372
, pp. 31-39
-
-
Kakkar, A.K.1
Brenner, B.2
Dahl, O.E.3
Eriksson, B.I.4
Mouret, P.5
Muntz, J.6
Soglian, A.G.7
Pap, A.F.8
Misselwitz, F.9
Haas, S.10
-
12
-
-
45949103416
-
Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty
-
Lassen MR, Ageno W, Borris LC, Lieberman JR, Rosencher N, Bandel TJ, Misselwitz F, Turpie AG. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty. N Engl J Med 2008; 358: 2776-86.
-
(2008)
N Engl J Med
, vol.358
, pp. 2776-2786
-
-
Lassen, M.R.1
Ageno, W.2
Borris, L.C.3
Lieberman, J.R.4
Rosencher, N.5
Bandel, T.J.6
Misselwitz, F.7
Turpie, A.G.8
-
13
-
-
65549169515
-
Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial
-
Turpie AG, Lassen MR, Davidson BL, Bauer KA, Gent M, Kwong LM, Cushner FD, Lotke PA, Berkowitz SD, Bandel TJ, Benson A, Misselwitz F, Fisher WD. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial. Lancet 2009; 373: 1673-80.
-
(2009)
Lancet
, vol.373
, pp. 1673-1680
-
-
Turpie, A.G.1
Lassen, M.R.2
Davidson, B.L.3
Bauer, K.A.4
Gent, M.5
Kwong, L.M.6
Cushner, F.D.7
Lotke, P.A.8
Berkowitz, S.D.9
Bandel, T.J.10
Benson, A.11
Misselwitz, F.12
Fisher, W.D.13
-
14
-
-
34250651947
-
Dose-escalation study of rivaroxaban (BAY 59-7939)-an oral, direct Factor Xa inhibitor-for the prevention of venous thromboembolism in patients undergoing total hip replacement
-
Eriksson BI, Borris LC, Dahl OE, Haas S, Huisman MV, Kakkar AK, Misselwitz F, Muehlhofer E, Kalebo P. Dose-escalation study of rivaroxaban (BAY 59-7939)-an oral, direct Factor Xa inhibitor-for the prevention of venous thromboembolism in patients undergoing total hip replacement. Thromb Res 2007; 120: 685-93.
-
(2007)
Thromb Res
, vol.120
, pp. 685-693
-
-
Eriksson, B.I.1
Borris, L.C.2
Dahl, O.E.3
Haas, S.4
Huisman, M.V.5
Kakkar, A.K.6
Misselwitz, F.7
Muehlhofer, E.8
Kalebo, P.9
-
15
-
-
28444474155
-
BAY 59-7939: an oral, direct factor Xa inhibitor for the prevention of venous thromboembolism in patients after total knee replacement. A phase II dose-ranging study
-
Turpie AG, Fisher WD, Bauer KA, Kwong LM, Irwin MW, Kalebo P, Misselwitz F, Gent M. BAY 59-7939: an oral, direct factor Xa inhibitor for the prevention of venous thromboembolism in patients after total knee replacement. A phase II dose-ranging study. J Thromb Haemost 2005; 3: 2479-86.
-
(2005)
J Thromb Haemost
, vol.3
, pp. 2479-2486
-
-
Turpie, A.G.1
Fisher, W.D.2
Bauer, K.A.3
Kwong, L.M.4
Irwin, M.W.5
Kalebo, P.6
Misselwitz, F.7
Gent, M.8
-
16
-
-
33644867218
-
Oral, direct Factor Xa inhibition with BAY 59-7939 for the prevention of venous thromboembolism after total hip replacement
-
Eriksson BI, Borris L, Dahl OE, Haas S, Huisman MV, Kakkar AK, Misselwitz F, Kalebo P. Oral, direct Factor Xa inhibition with BAY 59-7939 for the prevention of venous thromboembolism after total hip replacement. J Thromb Haemost 2006a; 4: 121-8.
-
(2006)
J Thromb Haemost
, vol.4
, pp. 121-128
-
-
Eriksson, B.I.1
Borris, L.2
Dahl, O.E.3
Haas, S.4
Huisman, M.V.5
Kakkar, A.K.6
Misselwitz, F.7
Kalebo, P.8
-
17
-
-
33751559902
-
A once-daily, oral, direct Factor Xa inhibitor, rivaroxaban (BAY 59-7939), for thromboprophylaxis after total hip replacement
-
Eriksson BI, Borris LC, Dahl OE, Haas S, Huisman MV, Kakkar AK, Muehlhofer E, Dierig C, Misselwitz F, Kalebo P. A once-daily, oral, direct Factor Xa inhibitor, rivaroxaban (BAY 59-7939), for thromboprophylaxis after total hip replacement. Circulation 2006b; 114: 2374-81.
-
(2006)
Circulation
, vol.114
, pp. 2374-2381
-
-
Eriksson, B.I.1
Borris, L.C.2
Dahl, O.E.3
Haas, S.4
Huisman, M.V.5
Kakkar, A.K.6
Muehlhofer, E.7
Dierig, C.8
Misselwitz, F.9
Kalebo, P.10
-
18
-
-
45949099359
-
Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty
-
Eriksson BI, Borris LC, Friedman RJ, Haas S, Huisman MV, Kakkar AK, Bandel TJ, Beckmann H, Muehlhofer E, Misselwitz F, Geerts W. Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty. N Engl J Med 2008; 358: 2765-75.
-
(2008)
N Engl J Med
, vol.358
, pp. 2765-2775
-
-
Eriksson, B.I.1
Borris, L.C.2
Friedman, R.J.3
Haas, S.4
Huisman, M.V.5
Kakkar, A.K.6
Bandel, T.J.7
Beckmann, H.8
Muehlhofer, E.9
Misselwitz, F.10
Geerts, W.11
-
19
-
-
84863224773
-
Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons
-
Gomez-Outes A, Terleira-Fernandez AI, Suarez-Gea ML, Vargas-Castrillon E. Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons. Br Med J 2012; 344: e3675.
-
(2012)
Br Med J
, vol.344
, pp. e3675
-
-
Gomez-Outes, A.1
Terleira-Fernandez, A.I.2
Suarez-Gea, M.L.3
Vargas-Castrillon, E.4
-
20
-
-
53449094159
-
Beyond the randomized clinical trial: the role of effectiveness studies in evaluating cardiovascular therapies
-
Nallamothu BK, Hayward RA, Bates ER. Beyond the randomized clinical trial: the role of effectiveness studies in evaluating cardiovascular therapies. Circulation 2008; 118: 1294-303.
-
(2008)
Circulation
, vol.118
, pp. 1294-1303
-
-
Nallamothu, B.K.1
Hayward, R.A.2
Bates, E.R.3
-
21
-
-
0029912547
-
Why we need observational studies to evaluate the effectiveness of health care
-
Black N. Why we need observational studies to evaluate the effectiveness of health care. Br Med J 1996; 312: 1215-8.
-
(1996)
Br Med J
, vol.312
, pp. 1215-1218
-
-
Black, N.1
-
22
-
-
85028124448
-
Estimates of population, by age group and sex
-
Accessed 26 August 2013.
-
Statistics Canada. Estimates of population, by age group and sex. Canadian Socioeconomic Database. 2013. http://www5.statcan.gc.ca/cansim/home-accueil?lang=eng. Accessed 26 August 2013.
-
(2013)
Canadian Socioeconomic Database
-
-
-
23
-
-
0038397012
-
Coding accuracy of administrative drug claims in the Ontario Drug Benefit database
-
Levy AR, O'Brien BJ, Sellors C, Grootendorst P, Willison D. Coding accuracy of administrative drug claims in the Ontario Drug Benefit database. Can J Clin Pharmacol 2003; 10: 67-71.
-
(2003)
Can J Clin Pharmacol
, vol.10
, pp. 67-71
-
-
Levy, A.R.1
O'Brien, B.J.2
Sellors, C.3
Grootendorst, P.4
Willison, D.5
-
24
-
-
33744506249
-
Accuracy of coding for possible warfarin complications in hospital discharge abstracts
-
Arnason T, Wells PS, van Walraven C, Forster AJ. Accuracy of coding for possible warfarin complications in hospital discharge abstracts. Thromb Res 2006; 118: 253-62.
-
(2006)
Thromb Res
, vol.118
, pp. 253-262
-
-
Arnason, T.1
Wells, P.S.2
van Walraven, C.3
Forster, A.J.4
-
25
-
-
0038519752
-
Risk of subsequent thromboembolism for patients with pre-eclampsia
-
van Walraven C, Mamdani M, Cohn A, Katib Y, Walker M, Rodger MA. Risk of subsequent thromboembolism for patients with pre-eclampsia. Br Med J 2003; 326: 791-2.
-
(2003)
Br Med J
, vol.326
, pp. 791-792
-
-
van Walraven, C.1
Mamdani, M.2
Cohn, A.3
Katib, Y.4
Walker, M.5
Rodger, M.A.6
-
26
-
-
0029878321
-
Characteristics and mortality outcomes of thrombolysis trial participants and nonparticipants: a population-based comparison
-
Jha P, Deboer D, Sykora K, Naylor CD. Characteristics and mortality outcomes of thrombolysis trial participants and nonparticipants: a population-based comparison. J Am Coll Cardiol 1996; 27: 1335-42.
-
(1996)
J Am Coll Cardiol
, vol.27
, pp. 1335-1342
-
-
Jha, P.1
Deboer, D.2
Sykora, K.3
Naylor, C.D.4
-
27
-
-
70449641720
-
Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research
-
Austin PC. Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research. Commun Stat Simul Comput 2009; 38: 1228-34.
-
(2009)
Commun Stat Simul Comput
, vol.38
, pp. 1228-1234
-
-
Austin, P.C.1
-
28
-
-
0032580320
-
Two-sided confidence intervals for the single proportion: comparison of seven methods
-
Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 1998; 17: 857-72.
-
(1998)
Stat Med
, vol.17
, pp. 857-872
-
-
Newcombe, R.G.1
-
29
-
-
66149131082
-
The relative merits of risk ratios and odds ratios
-
Cummings P. The relative merits of risk ratios and odds ratios. Arch Pediatr Adolesc Med 2009; 163: 438-45.
-
(2009)
Arch Pediatr Adolesc Med
, vol.163
, pp. 438-445
-
-
Cummings, P.1
-
30
-
-
33845382806
-
Nonparametric estimation from incomplete observations
-
Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-81.
-
(1958)
J Am Stat Assoc
, vol.53
, pp. 457-481
-
-
Kaplan, E.L.1
Meier, P.2
-
31
-
-
85028096516
-
-
OpenEpi: open source epidemiologic statistics for public health. Version 3.01. Accessed 4 June 2013.
-
Dean AG, Sullivan KM, Soe MM. OpenEpi: open source epidemiologic statistics for public health. Version 3.01. www.OpenEpi.com. Accessed 4 June 2013.
-
-
-
Dean, A.G.1
Sullivan, K.M.2
Soe, M.M.3
-
32
-
-
84891851890
-
A non-interventional comparison of rivaroxaban with standard of care for thromboprophylaxis after major orthopaedic surgery in 17,701 patients with propensity score adjustment
-
Turpie AG, Haas S, Kreutz R, Mantovani LG, Pattanayak CW, Holberg G, Jamal W, Schmidt A, van Eickels M, Lassen MR. A non-interventional comparison of rivaroxaban with standard of care for thromboprophylaxis after major orthopaedic surgery in 17, 701 patients with propensity score adjustment. Thromb Haemost 2014; 111: 94-102.
-
(2014)
Thromb Haemost
, vol.111
, pp. 94-102
-
-
Turpie, A.G.1
Haas, S.2
Kreutz, R.3
Mantovani, L.G.4
Pattanayak, C.W.5
Holberg, G.6
Jamal, W.7
Schmidt, A.8
van Eickels, M.9
Lassen, M.R.10
-
33
-
-
84904549901
-
-
Toronto, ON, Canada: Queen's Printer for Ontario
-
Ontario Ministry of Finance. Ontario Population Projections Update 2012-2036. Toronto, ON, Canada: Queen's Printer for Ontario, 2013.
-
(2013)
Ontario Population Projections Update 2012-2036
-
-
-
34
-
-
79952001310
-
Determining the test characteristics of claims-based diagnostic codes for the diagnosis of venous thromboembolism in a medical service claims database
-
Tagalakis V, Kahn SR. Determining the test characteristics of claims-based diagnostic codes for the diagnosis of venous thromboembolism in a medical service claims database. Pharmacoepidemiol Drug Saf 2011; 20: 304-7.
-
(2011)
Pharmacoepidemiol Drug Saf
, vol.20
, pp. 304-307
-
-
Tagalakis, V.1
Kahn, S.R.2
-
35
-
-
84861402643
-
Aspirin for preventing the recurrence of venous thromboembolism
-
Becattini C, Agnelli G, Schenone A, Eichinger S, Bucherini E, Silingardi M, Bianchi M, Moia M, Ageno W, Vandelli MR, Grandone E, Prandoni P. Aspirin for preventing the recurrence of venous thromboembolism. N Engl J Med 2012; 366: 1959-67.
-
(2012)
N Engl J Med
, vol.366
, pp. 1959-1967
-
-
Becattini, C.1
Agnelli, G.2
Schenone, A.3
Eichinger, S.4
Bucherini, E.5
Silingardi, M.6
Bianchi, M.7
Moia, M.8
Ageno, W.9
Vandelli, M.R.10
Grandone, E.11
Prandoni, P.12
-
36
-
-
84869441338
-
Low-dose aspirin for preventing recurrent venous thromboembolism
-
Brighton TA, Eikelboom JW, Mann K, Mister R, Gallus A, Ockelford P, Gibbs H, Hague W, Xavier D, Diaz R, Kirby A, Simes J. Low-dose aspirin for preventing recurrent venous thromboembolism. N Engl J Med 2012; 367: 1979-87.
-
(2012)
N Engl J Med
, vol.367
, pp. 1979-1987
-
-
Brighton, T.A.1
Eikelboom, J.W.2
Mann, K.3
Mister, R.4
Gallus, A.5
Ockelford, P.6
Gibbs, H.7
Hague, W.8
Xavier, D.9
Diaz, R.10
Kirby, A.11
Simes, J.12
-
37
-
-
84878738746
-
Aspirin versus low-molecular-weight heparin for extended venous thromboembolism prophylaxis after total hip arthroplasty: a randomized trial
-
Anderson DR, Dunbar MJ, Bohm ER, Belzile E, Kahn SR, Zukor D, Fisher W, Gofton W, Gross P, Pelet S, Crowther M, MacDonald S, Kim P, Pleasance S, Davis N, Andreou P, Wells P, Kovacs M, Rodger MA, Ramsay T, et al. Aspirin versus low-molecular-weight heparin for extended venous thromboembolism prophylaxis after total hip arthroplasty: a randomized trial. Ann Intern Med 2013; 158: 800-6.
-
(2013)
Ann Intern Med
, vol.158
, pp. 800-806
-
-
Anderson, D.R.1
Dunbar, M.J.2
Bohm, E.R.3
Belzile, E.4
Kahn, S.R.5
Zukor, D.6
Fisher, W.7
Gofton, W.8
Gross, P.9
Pelet, S.10
Crowther, M.11
MacDonald, S.12
Kim, P.13
Pleasance, S.14
Davis, N.15
Andreou, P.16
Wells, P.17
Kovacs, M.18
Rodger, M.A.19
Ramsay, T.20
more..
|